Milner Therapeutics Institute, University of Cambridge

Our Mission: Bringing discoveries to life

Lives can be transformed when the strength of academia and business combine. As a biomedical institute, we act as a catalyst and a driver, forming dynamic partnerships to unlock the power of emerging discoveries. The Milner Therapeutics Institute encompasses both a research institute and a global outreach programme, which aims to transform pioneering science into therapies.

1. Our institute on the biomedical campus provides a physical hub that combines the strength of academia and business to accelerate the development of therapies. Our own in-house research programme in the Centre for Pathway Analysis has built a mass of expertise in computational research and functional genomics, with a growing network of collaborative research partners.

2. Our institute is the headquarters of the Milner Therapeutics Consortium, a partnership of twelve Pharma companies and three academic Institutions. This consortium provides unique and diverse routes for our partners to engage with Cambridge academics and entrepreneurs. By creating innovative models of cross-sector collaboration, the Milner model provides a leading example internationally of how academic discoveries can move from the lab and into developmental pipelines that result in effective therapies.

3. We support entrepreneurs through our Frame Shift Bio-incubator, through our partnership with the Start Codon Venture Builder and Investor, and through the Bio-spark early-stage entrepreneurial programme. We are the biomedical hub for Connect: Health Tech, and we work with other University organizations to create a wealth of resources and commercial support for academics seeking to put ideas into practice.